Asia Pacific Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To 2021)

Asia Pacific Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To 2021)

ID: 4986 | Pages: 145 | November 2017 | Region: Asia Pacific


Asia Pacific Cardiac Marker Testing market Size is expected to grow at 11.7% CAGR from 2016 to 2021 and it is projected that the Asia-Pacific market was valued at USD 0.37 billion in 2016 and is anticipated to reach USD 0.64 billion by 2021.

Cardiac Bio-Marker Diagnostic Test market includes the diagnostic tests used to measure the concentration of proteins, also known as biomarkers that indicate the occurrence and phase of cardiovascular disease (CVD). Cardiac biomarkers evaluate the heart function and aid in identifying the complexity and severity of procedures further required to treat the cardiovascular disease. The primary indications for cardiovascular diseases are Acute Coronary Syndrome (ACS) which include Angina Pectoris (AP) and Acute Myocardial Infraction (AMI) Congestive Heart Failure (CHF), Peripheral Artery Disease (PAD) and others.  The major causes of CVD are High Blood Pressure, smoking, diabetes, inadequate exercise, stress, unhealthy diet, alcoholism, obesity and high blood cholesterol. More than half of the cardiovascular diseases can be cured if diagnosed at the right time.

Factor such as increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

The Asia Pacific Cardiac Marker Testing Market segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.

On the basis of geography, the market is analyzed under various regions namely India, China, Japan, Australia and South Korea. Asia-Pacific market is expected to register the highest growth. Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cardiac biomarkers. Rising prevalence and incidence of cardiovascular diseases is among the major driving factors for the growth of this market in China and India. For instance, annual cardiovascular events in China were projected to increase by more than 50% from 2010 to 2030. China has one of the highest CVD death rates in the world and it is estimated that one in 5 adults in China has a cardiovascular disease. In addition to this, public–private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors propelling the demand for cardiac biomarkers in the emerging markets.

Some of the companies dominating the market are bioMérieux SA, LSI Medience Corporation, Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere, Inc., Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Reagents and Kits                                

                                5.1.3 Instruments                                           

                                                5.1.3.1 Chemiluminescence                        

                                                5.1.3.2 Immunofluorescence                     

                                                5.1.3.3 Elisa                        

                                                5.1.3.4 Immunochromatography                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                            

                                5.1.6  Market Share Analysis, By Product                                              

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Troponin I & T                                        

                                5.2.3 CK-MB                                      

                                5.2.4 Myoglobin                                               

                                5.2.5 BNP                                            

                                5.2.6 hsCRP                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 Disease                                                        

                                5.3.1 Introduction                                           

                                5.3.2 Acute Coronary Syndrome                                               

                                5.3.3 Myocardial Infarction                                         

                                5.3.4 Congestive Heart Failure                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease                                                

                                5.3.6  Market Attractiveness Analysis, By Disease                                             

                                5.3.7  Market Share Analysis, By Disease                                              

                5.4 Type of Testing                                                         

                                5.4.1 Introduction                                           

                                5.4.2 Lab                                             

                                5.4.3 Point-Of-Care Testing                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing                                                

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                             

                                5.4.6  Market Share Analysis, By Type of Testing                                               

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Type                 

                                                6.1.3.4 By Disease                           

                                                6.1.3.5 By Type of Testing                            

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Type                 

                                                6.1.4.4 By Disease                           

                                                6.1.4.5 By Type of Testing                            

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Type                 

                                                6.1.5.4 By Disease                           

                                                6.1.5.5 By Type of Testing                            

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Getinge Group                                                          

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc                                                            

                8.3 LivaNova PLC                                                             

                8.4 XENIOS Roche Diagnostics Ltd.                                                           

                8.5 Abbott Laboratories                                               

                8.6 Siemens AG                                               

                8.7 Danaher Corporation                                                             

                8.8 Alere Inc.                                                     

                8.9 BioMérieux SA                                                          

                8.10 LSI Medience Corporation                                                 

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, Product, Disease and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Troponin I & T Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Insulin Delivery Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific CK-MB Market By Region, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Myoglobin Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific BNP Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific hsCRP Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Reagent Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Instrument Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Chemiluminescence Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Immunofluorescence Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Immunochromatography Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific ELISA Market By Region, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Acute Coronary Syndrome Market By Region, From 2016-2021 ( USD Billion )
  17. Asia-Pacific Myocardial Infarction Market By Region, From 2016-2021 ( USD Billion )
  18. Asia-Pacific Congestive Heart Failure Market By Region, From 2016-2021 ( USD Billion )
  19. Asia-Pacific Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
  20. Asia-Pacific Lab Market By Region, From 2016-2021 ( USD Billion )
  21. Asia-Pacific POC  Market By Region, From 2016-2021 ( USD Billion )
  22. Japan Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  23. Japan Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  24. Japan Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  25. Japan Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
  26. China Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  27. China Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  28. China Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  29. China Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
  30. India Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  31. India Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  32. India Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  33. India Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
  34. Australia Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  35. Australia Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  36. Australia Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  37. Australia Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
  38. South Korea Cardiac Marker Testing  Market By Type, From 2016-2021 ( USD Billion )
  39. South Korea Cardiac Marker Testing  Market By Product, From 2016-2021 ( USD Billion )
  40. South Korea Cardiac Marker Testing  Market By Disease, From 2016-2021 ( USD Billion )
  41. South Korea Cardiac Marker Testing  Market By Testing, From 2016-2021 ( USD Billion )
Middle East And Africa Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, An...
Latin America Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others)...
Asia Pacific Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others),...
Europe Infant Incubator Market Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others), And By R...
North America Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others)...
Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others), And By Regio...
Middle East And Africa Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (AS...
Latin America Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And ...
Asia Pacific Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And B...
Europe Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And By Regi...
North America Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And ...
Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And By Region - Gl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.